The DNA unwinding effects of some 9-anrinoacridine derivatives were compared under reaction conditions that could be used to study druginduced topoisomerase II inhibition. An assay was designed to determine drug-induced ONA unwinding by using L1210 topoisomerase I. 9-aminoacridines could be ranked by decreasing unwinding potency: compound C > 9-aminoacridine > o-AMSA > compound A > compound B > m-AMSA. Ethidium bromide was more potent than any of the 9-aminoacridines. This assay is a fast and simple method to compare DNA unwinding effects of intercalators. It led to the definition of a drug intrinsic unwinding constant (k). An additional finding was that all 9-aminoacridines and ethidium bromide inhibited L1210 topoisomerase I. Enzyme inhibiton was detectable at low enzyme concentrations (< 1 unit) and when the kinetics of topoisomerase I-mediated DNA relaxation was studied. Topoisomerase I inhibition was not associated with DNA swivelling or cleavage.
INTRODUCTION
Many DNA intercalators have been synthesized in the acridine series.
Acridine orange is used for physicochemical studies of DNA; quinacrine is a potent antimalarial and antihelmintic drug and amsacrine (m-AMSA) is used as an anticancer agent in human acute leukemia (1-7). The antitumor effect of m-AMSA is associated with the production protein-linked DNA strand breaks in mammalian cells in culture (8). It is now established that these peculiar DNA breaks result from topoisomerase II inhibition (9-11). m-AMSA is thought to trap topoisomerase II by freezing abortive intermediates of the DNA strand passing reaction, in which the enzyme is bound to the 5'-termini of the breaks it catalyzes (9-12). Although this effect can be observed easily in purified systems, it is not known whether the inhibitory effect of m-AMSA upon topoisomerase II-DNA complexes is due solely to DNA intercalation.
Before undertaking our studies with topoisomerase II (13), we sought to The DNA intercalative potencies of the 9-aminoacridines were determined by using a DNA unwinding assay using LI21D topoisomerase I. In the course of these experiments, we found that 9-aminoacridine intercalators and ethidium bromide could inhibit LI210 topoisomerase I-mediated DNA relaxation. Topoisomerase I was purified from mouse leukemia (LI210) cell nuclei, as described previously (9). Enzyme purity was checked by sodium dodecylsulfate polyacrylamide gels (one 100 kD band). One unit topoisomerase I was defined as the lowest enzyme activity required to relax 0.4 ug native SV40 DNA completely, in the conditions described below.
MATERIALS AND METHODS

Materials
Topoisomerase Reactions
Reactions were performed in buffer B (0.01 M Tris-HCl, pH 7.5, 0.05 M KC1, 5 mM MgCl2, 0.1 mM Na2EDTA, 15 ug/ml bovine serum albumin), in the absence of ATP. 0.4 ug SV40 DNA was reacted with the indicated amounts of LI210 topoisomerase I, in the absence or presence of drugs, for 30 min at 37 C C. Reactions volumes were typically 30 pi. Reactions were stopped by adding sodium dodecylsulfate (NaDoSO/j) and proteinase K (Merck, Darmstadt, West Germany) (1% and 0.5 mg/ml, final concentrations respectively). After an additional 30 min at 37°C, an appropriate volume of (10 x) loading buffer (0.3% bromophenol blue, 16% Ficoll, 0.01 M Na2HP04) was added. None of the drugs modified DNA migration.
Agarose Gel Electrophoresis
One percent agarose gels were made in Tris-Acetate-EDTA (TAE) buffer (0.04 M Tris-Acetate, pH 7.6, 0.01 M Na^HTA). Gels were run at 1 V/cm overnight and then stained with 1 pM ethidiun bromide for 45 min. After an additional 30 min destaining in 1 mM Mg2S04, the gels were photographed under U.V. light with Polaroid 55 or 57 films. To obtain the curves shown on Figure 4 , the distance between the migration positions of negatively supercoiled and nicked relaxed SV40 DNA was measured from the densitometer scanning (Beckman DU 8B) of the negative of a given gel and set as control migration. Migration distances of each individual DNA topoisomer resulting from topoisomerase I action in the absence or presence of drug, was also measured relative to the position of nicked relaxed DNA. The ratio between this distance and that of control migration was computed and plotted versus number of superhelical turns per SV40 molecule, as determined by band counting (14-16), knowing that neighbor topoisomers differ by one superlical turn. Determination of Intercalator Intrinsic Unwinding Constants (k)
The total drug-induced reduction of DNA twist for a N base-pair duplex circular DNA molecule is: 2 N r * where r is the number of intercalated drug molecules per nucleotide and $ the DNA unwinding angle for each intercalated molecule. Topoisomerase I action adjusts DNA linking number (Lk : number of crossover points of one DNA single-strand over the other) to the modified DNA twist (14-18), in such a way that:
2 N r * = 360 x ALk Lk change (ALk) was determined by band counting assuming ALk = 1 between adjacent DNA topoisomers, and 360° is the unwinding angle between adjacent DNA topoisomers. The above equation can be rewritten: r * = 360 ALk / 2N (1) r* corresponds to the intercalator-induced unwinding per nucleotide. Knowing « (Table II) Topoisomerase I-mediated DNA relaxation was quantified by densitomer scanning of the negatives of agarose gels. The fraction of DNA in the supercoiled band (S) was calculated in untreated native DNA (So), in enzyme-treated DNA (S E ), and in DNA treated with enzyme and various drug concentrations (S E n,). The percent inhibition of relaxation at a given drug concentration was calculated by using the formula:
[(S ED -S E ) / (S 0 -S E )] x 100% Drug concentrations yielding 30% inhibition [Ci(30%)] were then derived. 2) for the following reason?'. First, if only the assay with relaxed DNA were used and no final modification of the DNA occurred, it would be impossible to know whether the drug inhibited topoisomerase I or did not intercalate. The parallel use of supercoiled ONA eliminates lack of intercalation as an explanation for an absence of supercoiled DNA relaxation. A second reason for performing the unwinding assay both with supercoiled and relaxed DNA is that the observation of similar DNA end-products with both DNA substrates ensures that no drug remained bound during electrophoresis and that the measured DNA linking number change (ALk = |Lk'-Lk| = |Lk'-Lk"|) is an accurate measurement of drug unwinding (ATW = |Tw-Tw'|) ( Figure 2 ). Finally, DNA intercalation is characterized by a DNA unwinding that occurs independently of the supercoiling state of the DNA substrate (22). Thus, this characteristic effect can be easily monitored by using both negatively supercoiled and closed circular DNA. Relationship between DNA migraton and number of superhelical turns per SV40 molecule in 1% agarose gels in TAE buffer. The distance between nicked relaxed and native SV40 DNA was measured from the densitometer scanning of agarose gels and set as 100% migration (control) with 25 superturns. The distance between individual DNA topoisomers and nicked relaxed DNA was also measured and normalized to control. Drug unwinding studies were performed in buffer B (0.01 M Tris.HCl, pH 7.5, 0.05 M KC1, 5 mM MgCl2. 0.01 mM Na2EDTA, 15 ug/ml Dovine serum albumin). * 9-aminoacridine is abbreviated 9-AA Ct is the total drug concentration. ALk is the DNA linking number change (absolute value) measured in the topoisomerase I unwinding assay, r is the number of drug molecules bound per nucleotide. * is the unwinding angle produced by intercalated drug molecule, is the drug-induced ONA unwinding per nucleotide [equation (1)]. is the free drug concentration [equation (2)]. is the intrinsic unwinding constant for drug [equation (3)]. Table I ). The conversion from total to free drug concentration was performed as described under Materials and Methods and Table I . r$, which corresponds to the intercalator-induced DNA unwinding per nucleotide, was calculated for each drug at various concentrations (Equation (1) and Table I ments with calf thymus DNA, showed also that the apparent binding affinity constant for ethidium bromide was 2-to 3-fold greater at 25°C than at 37°C (18.5 versus 6.5 x 10* M~*). Therefore, equilibrium drug binding is lower at higher temperatures. Figure 5 shows the relationship between ALk (drug-induced DNA unwinding) and free drug concentrations. 9-aminoacridine compounds varied widely in their DNA unwinding potencies and where all less potent than ethidiuni bromide. For all compounds, ALk was proportional to the free drug concentration. Therefore, even at the highest drug concentrations, the DNA was not saturated, and drug-induced DNA unwinding was independent of DNA superhelicity. Drug intrinsic unwinding constants (k) are proportional to the slopes of the lines shown on Figure 5 (see equations (1) and (3) ; Materials and Methods), k was independent of the drug concentration for a given drug but was specific of each intercalator (Table I) . Ethidium bromide appeared 4-5-fold more potent than 9-aminoacridine or compound C, which were 3-fold more potent than compound A and o-AMSA, which were 1.5-fold more potent Figure 6 : Effect of MgCi2 upon 9-aminoacridine-induced DNA unwinding as measured by the topoisomerase I unwinding assay. Native SV40 DNA and topoisomerase I were reacted with 9-aminoacridine in the presence of excess enzyme. Reactions were stopped and gels run as described in the legend of Figure 3 . Drug-induced DNA unwinding and free drug concentration were determined as described in the legend of Figure 5 . than compound B, which was 1.8-fold more potent than m-AMSA. It is particularly striking that o-AMSA was 2.7-fold more potent than its stereoisomer m-AMSA in unwinding DNA. Since both drugs have a similar unwinding angle (« = 20.5°), this difference has to be due to differences in DNA binding constants (22, 23).
RESULTS
Determination of
The topoisomerase I unwinding assay can be used to study various buffer conditions. Figure 6 shows that the 9-aminoacridine-induced DNA unwinding was more pronounced in the absence of MgCl2-The intrinsic unwinding constant was approximately 3-fold greater than in the presence of 5 mM MgCl2 (k = 0.21 versus 0.07). k did not change upon lowering the KC1 concentration from 50 to 25 mM; data not shown). However, topoisomerase I catalytic activity was reduced at these lower ionic concentrations and was abolished when KC1 was omitted from buffer B. Topoisomerase I inhibition by m-AMSA was analyzed further by looking at enzyme kinetics in the absence or presence of 20 yM m-AMSA (Figures 8 and  9 ). In the absence of m-AMSA, 1 unit topoisomerase I relaxed SV40 DNA with nearly first order kinetics and a half-time of 1.5 min (Figure 9) . Again, at the earliest time points the DNA was either fully relaxed or fully supercoiled (panel A, Figure 8 ) confirming the processive nature of the reaction. In the presence of m-AMSA, the DNA relaxation kinetics was much slower, although still first order (t !/ 2 = 10 min, Figure 9 ) and without DNA topoisomers of intermediate superhelicity (panel B, Figure  8 ). Increasing the incubation time to 45 min (Figure 8 , lower right lane) allowed the reaction to go to completion in the presence of m-AMSA. Therefore the inhibitory effect of m-AMSA seems to result from a reversible inhibition of topoisomerase I either before or after one full catalytic cycle or from a slowing of the enzyme reaction in the presence of bound drug.
The other 9-aminoacridines and ethidium bromide also inhibited topoisomerase I-mediated DNA relaxation. The inhibition was detectable at low enzyme concentrations and was drug concentration-dependent (Figure 10 ). The inhibitory effects of DNA intercalators upon 1 unit of topoisomerase I were then compared (Table II) . 30% inhibition was chosen for comparison because of the weak potency of some derivatives at concentrations that relaxed significantly the DNA and produced topoisomer shifts that made difficult the identification of a true topoisomerase I inhibition. The drug concentrations producing 30% topoisomerase I inhibition [Ci(30%)] varied between 1 pM (ethidium bromide) and 20 uM (compound B) (Table II) . Intercalators could be ranked by decreasing topoisomerase I inhibitory effect: ethidium bromide > 9-aminoacridine = compound C > m-AMSA > compound A > o-AMSA > compound B. The relationship between topoisomerase I inhibition and intercalator-induced DNA unwinding was analyzed by using the drug intrinsic unwinding constants [(k), equation 3, Table I ]. Drug-induced DNA unwinding being proportional to r« (equation 1), and r« equal to kC (equation 3), kC was determined for each drug at their Ci(30%) ( Table II) . This calculation gives only an approximative value for r since it was performed by assuming equivalence between total (C t ) and free drug concentration (C). However, Table I shows that such an assumption can be made for all 9-aminoacridines. Only in the case of ethidium, using C instead of C^ would give a smaller unwinding angle (0.22 instead of 0.33). Nearly similar values were obtained for 9-aminoacridine, o-AMSA, compounds B and C. Therefore, topoisomerase I inhibition seems to related to DNA unwinding for these drugs. However, in the case of m-AMSA and compound A, 30% topoisomerase I inhibition was produced by drug concentrations that produced less ONA unwinding.
DISCUSSION
The most generally accepted criteria for drug intercalation are that: 1) the DNA helix is extended and 2) locally unwound by drug binding, and that 3) the plane of the aromatic chromophore of the bound drug is parallel to that of the base pairs (2, 22, 30). Drug-induced DNA unwinding is the most selective criterion of drug intercalation although the fulfillment of all three criteria should be met in order to classify a compound as an intercalator. Intercalation leads to a typical biphasic response in assays measuring drug-induced DNA unwinding of native DNA (22, 31-33). Negative superhelical turns are only partially removed at low levels of drug intercalation. Increasing the bound intercalator increases the unwinding up to an "equivalence-point", where all superturns are removed. Relaxed DNA migrates more slowly than supercoiled DNA in sedimentation and electrophoresis techniques. At drug concentrations exceeding the equivalence-point, the unwinding effect of intercalation introduces positive superturns and the DNA migrates faster. The DNA unwinding assay using mammalian topoisomerase I is based upon the above concept. However, instead of putting the drug into the running buffers, it is added to the reaction mixtures prior to electrophoresis (33) (34) (35) . Each electrophoresis lane is used to assay a single drug concentration. Buffer, temperature, DNA or topoisomerase I conditions can be studied because mammalian topoisomerase I processes DNA under variable conditions (36) (37) (38) . This is not the case of prokaryotic topoisomerase I, which cannot relax positively supercoiled DNA (36) (37) (38) . The determination of drug intrinsic unwinding constants (k = r * / C) can be done easily from the agarose gels results (which give r <) > ), but requires the concurrent determination of C (free drug concentration). C can be calculated only if * is known. However, at low drug binding densities, C can be equated to C^ (total drug concentration). Table I shows that it was the case for 9-aminoacridine compounds.
Small changes in the substituents on the anilino moiety resulted in marked changes in the DNA unwinding characteristics of 9-aminoacridines. This was particularly clear for the two isomers, m-AMSA and o-AMSA since the intrinsic unwinding constant of o-AMSA was 2-to 3-fold greater than that of Table II •» 
